Home > Newsletters > FDAnews Drug Daily Bulletin > Pharma Stakeholders Call for Global Marketing Application
FDAnews Drug Daily Bulletin
June 19, 2012 | Vol. 9 No. 120
Pharma Stakeholders Call for Global Marketing Application
The FDA should work with other regulatory bodies, especially the European Medicines Agency (EMA), to create a single marketing application that would be accepted by multiple regulators, drug industry insiders urge. The Biotechnology Industry Organization (BIO) wants the agency to harmonize both the content and structure of drug applications so sponsors can submit the same dossier to several agencies. This would allow drugmakers and regulatory agencies to save resources.
Washington Drug Letter
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.